Perennial Allergic Rhinitis (PAR)

DBCOND0058482Immune System DiseasesInfections

Perennial Allergic Rhinitis (PAR) is the indication for 18 drugs in DrugBank. It is covered by 19 curated, structured indications.

Also known as
Rhinitis, Allergic, Perennial · Rhinitis, Allergic, Nonseasonal · Perennial Allergic Rhinitis · Non-seasonal Allergic Rhinitis · perennial alleric rhinitis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0019020ICD-10J30.89SNOMED CT155537009MedDRA10001723UMLSC0002103

What you can answer from here — as of October 22, 2026

18Indicated drugsWith each drug's targets and mechanism
Listed above
19Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
181Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Perennial Allergic Rhinitis (PAR) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In